#breastpath destiny of her2/neu in the era of her2-low in 2024
Published Streamed 9 months ago • 4.9K plays • Length 58:05Download video MP4
Download video MP3
Similar videos
-
2:30
destiny-breast04: t-dxd in her2-low breast cancer regardless of molecular markers
-
23:49
oncology today with dr neil love: optimizing the identification of her2-low breast cancer
-
2:01
destiny-breast04: practice-changing results for her2-low breast cancer
-
11:25
podcast 293: her2-“low” breast cancer and its reponse to an antibody-drug conjugate
-
0:44
biomarker-based personalization for her2-low breast cancer treatment in destiny-breast04
-
11:12
her2-low breast cancer: destiny or good science?
-
4:11
what is her2 positive breast cancer? | treatment/therapies for her2 positive breast cancer
-
2:10:40
destroy canc*r cells with this 10000hz 528hz healing frequency music
-
15:00
new fda-approved targeted drug for treatment-resistant, er positive her2 negative breast cancer
-
23:49
optimizing the identification of her2-low breast cancer
-
1:32
destiny-breast15: t-dxd in patients with hr hr- and her2-low or her2 ihc 0 metastatic breast cancer
-
5:16
treatment options for her2-low breast cancer: all you need to know
-
1:25:22
a new view of the spectrum of her2 expression and significance of her2 low in breast cancer
-
1:08
updated survival results of destiny-breast03: t-dxd vs t-dm1 in her2 metastatic breast cancer
-
39:40
optimizing the identification of her2-low breast cancer (video lecture)
-
1:14
destiny-breast04: exploring t-dxd and io combinations in her2-low breast cancer
-
1:09
the exciting new field of her2-low breast cancer
-
54:43
the science of her2-low breast cancer and implications for the pathology team
-
7:13
overview of the management of her2-low breast cancer patients
-
21:19
estrogen receptors & her2/neu receptors in breast cancer (a tutorial from oster oncology)
-
2:30
prognostic value of her2-low status in breast cancer: a systematic review and meta-analysis
-
25:20
her2 low breast cancer a new therapeutic subtype | 2023 ku breast cancer year in review conference